• Copper-Coordinated Nanoassembly Triggers Cuproptosis for Can

  2026-07-26

  This study presents a baicalein–copper nanoassembly (BCB) that integrates chemodynamic and photodynamic activities to induce cuproptosis and robust tumor ablation, notably in bone-metastatic cancers. The approach overcomes key limitations of previous copper-based nanotherapeutics by achieving stable, tumor microenvironment-responsive copper release and multimodal ROS generation.

• Selective β1-Blockade Preserves Hematopoietic Regeneration A

  2026-07-25

  This study demonstrates that nonselective β-adrenergic blockers impair hematopoietic regeneration after hematopoietic cell transplantation (HCT), whereas selective β1-blockade with Metoprolol Tartrate does not hinder recovery. These findings highlight receptor-specific effects critical for post-transplant care and experimental modeling.

• KX2-391 Dihydrochloride: Applied Protocols in Oncology & Vir

  2026-07-24

  KX2-391 dihydrochloride (Tirbanibulin dihydrochloride) brings dual pathway inhibition and robust solubility to cancer, virology, and neurotoxin research. Its track record in high-content screening and translational workflows offers a uniquely versatile tool for both mechanistic interrogation and applied drug discovery.

• Telmisartan: Applied Workflows for Cardiac Hypertrophy Resea

  2026-07-24

  Telmisartan, a potent angiotensin II receptor antagonist from APExBIO, enables precision modeling of cardiac hypertrophy by targeting the AT1 receptor and modulating key signaling pathways. This article delivers actionable protocol enhancements and troubleshooting strategies to maximize reproducibility and insight in cardiovascular disease research.

• Idoxuridine (SKU B1773): Precision in Antiviral Assays

  2026-07-23

  This article addresses real-world laboratory challenges in antiviral research, with a focus on reproducibility, data interpretation, and workflow optimization using Idoxuridine (SKU B1773). Readers will discover evidence-backed guidance and candid vendor comparisons to streamline experiment design and outcome reliability.

• Intravesical p21 mRNA-LNP Therapy Suppresses Bladder Cancer

  2026-07-23

  The reference study establishes a novel, non-viral approach for bladder cancer treatment using intravesical delivery of lipid nanoparticles loaded with chemically modified p21 mRNA. This strategy restores local p21 expression, significantly inhibits tumor growth, and minimizes systemic toxicity, offering a targeted advance in mRNA-based cancer therapeutics.

• Rotigotine Hydrochloride: Advancing Dopaminergic Research

  2026-07-22

  This thought-leadership article explores the mechanistic action, translational research protocols, and strategic value of Rotigotine hydrochloride as a dopamine D2/D3 receptor agonist. It provides evidence-based insights for Parkinson’s disease and restless legs syndrome research, contextualizes APExBIO’s reagent within a competitive landscape, and delivers actionable recommendations for translational teams seeking reliable, reproducible, and mechanistically sound experimental workflows.

• GSK343: EZH2 Inhibitor Workflows for Precision Epigenetic Ca

  2026-07-22

  GSK343 is a nanomolar, cell-permeable EZH2 inhibitor that unlocks targeted interrogation of histone H3K27 methylation and gene repression in cancer models. This guide delivers actionable in vitro workflows, troubleshooting insights, and advanced use-cases for leveraging GSK343 in epigenetic cancer research, drawing on the latest mechanistic findings and protocol best practices.

• Cell Counting Kit-8 (CCK-8): Mechanistic Insights and Advanc

  2026-07-21

  Explore the advanced mechanism and unique assay benefits of Cell Counting Kit-8 (CCK-8) for cell proliferation, viability, and cytotoxicity measurement. This in-depth analysis reveals how CCK-8 empowers precision research beyond standard protocols.

• Co-targeting BRD4 and RAC1 Disrupts c-MYC-G9a Axis in Breast

  2026-07-21

  This article examines a recent study revealing that simultaneous inhibition of BRD4 and RAC1 disrupts the c-MYC-G9a-FTH1 signaling axis, thereby suppressing growth, stemness, and tumorigenicity in diverse breast cancer subtypes. The findings highlight novel epigenetic intervention points and provide mechanistic insight into histone methyltransferase inhibition as a therapeutic strategy.

• ECL Chemiluminescent Substrate Detection Kit for Ultra-Sensi

  2026-07-20

  Unlock low-picogram protein detection and extended signal clarity with the Enhanced ECL Chemiluminescent Substrate Detection Kit from APExBIO. This guide delivers actionable workflow strategies, troubleshooting insights, and protocol upgrades rooted in breakthrough RCC ferroptosis research.

• Dabigatran in Thromboembolic Disorders: Evidence and Implica

  2026-07-20

  The reference study provides a comprehensive evaluation of dabigatran, a direct oral thrombin inhibitor, for the prevention and treatment of thromboembolic disorders. The review highlights dabigatran’s rapid onset, predictable pharmacokinetics, and favorable safety profile relative to warfarin, with implications for stroke prevention in atrial fibrillation and venous thromboembolism management.

• Technical Use of 5X Protein Loading Buffer (Reducing) in SDS

  2026-07-19

  5X Protein Loading Buffer (Reducing) addresses the need for consistent protein denaturation and disulfide bond reduction in SDS-PAGE, enabling accurate separation by molecular weight. It is suitable for workflows requiring reducing conditions, but should not be used for experiments where protein native structure or non-reducing conditions must be preserved.

• Reversine: Advancing Aurora Kinase Inhibition in Cancer Rese

  2026-07-18

  This thought-leadership article synthesizes mechanistic insights into Aurora kinase signaling, the evolving role of mitotic checkpoint modulation, and strategic recommendations for translational researchers leveraging Reversine. Bridging foundational biology with actionable guidance, it positions Reversine as a uniquely potent research tool for dissecting cell cycle control and cancer cell proliferation.

• Propidium Iodide: Precision DNA Intercalating Dye for Advanc

  2026-07-17

  Propidium iodide (PI) stands apart as an essential DNA intercalating dye for distinguishing viable, apoptotic, and necrotic cells with high fidelity in fluorescence-based assays. This article translates leading-edge research and hands-on troubleshooting into actionable guidance, empowering users of APExBIO’s PI for next-generation cell viability, apoptosis, and cell cycle workflows.

449 records 10/30 page Previous Next First page 上5页 678910 下5页 Last page